The T preparing carriers method that is used for the T-A clone
Technical field
The present invention relates to a kind of method that makes up plasmid vector in the genetically engineered field, particularly relate to the method that adopts the preparation of unique biological synthesis method to be used for T-A clone's T carrier.
Background technology
T-A cloning (Clark, J.M.Novel non-templated nucleotide addition reactionscatalyzed by procaryotic and eucaryotic DNA polymerases (nucleic acid of new protokaryon or the catalytic non-template dependent form of eukaryotic DNA polysaccharase adds reaction) .Nucleic Acids Res.1988,16,9677-9686; Marchuk, D., Drumm, M., Saulino, A.and Collins, F.S.Construction ofT-vectors, a rapid and general system for direct cloning of unmodified PCR product (structure of T carrier, a kind of system of the general original PCR product of direct clone fast) .Nucleic Acids Res.1991,19,1154; Holton, T.A.and Graham, M.W.A simple and efficient method fordirect cloning of PCR products using ddT-tailed vectors (a kind of simple and effective method of utilizing the direct clone PCR products of ddT overhang carrier) .Nucleic Acids Res.1991,19,1156; Mead, D.A., Pey, N.K., Herrnstadt, C., Marcil, R.A.and Smith, L.M.A universal method forthe direct cloning of PCR amplified nucleic acid (a kind of universal method that is used for direct clone PCR products) .Biotechnology (N Y) .1991,9, be to be accompanied by a kind of cloning process that round pcr grows up 657-663).PCR product cloning to 3 ' end that so-called T-A clone has 3 ' end single A tail exactly has on the T carrier of single T tail.T-A clone's theoretical foundation is: in the pcr amplification process, because the Taq polysaccharase has the terminal enzyme (DNA) activity of the template of not relying on and adds single deoxynucleotide at 3 of PCR product ' end, and preference is added the deoxyadenylic acid (A) in four kinds of deoxynucleotides, make 3 ' end of the PCR product more than 50% have single deoxyadenylic acid, i.e. 3 ' end A tail.Therefore people develop carrier---the T carrier of a kind of 3 ' end with an outstanding T, do the linear DNA segment of A-tailing operation with the Taq enzyme with the PCR product that is used to clone the taq enzymatic amplification or other.
At present, the preparation method of T carrier has three kinds.First method is to utilize the restriction endonuclease that produces flat end that the cyclic plasmid enzyme is cut into the wire plasmid, utilize terminal enzyme (DNA) to add single ddTTP to 3 of wire carrier ' end (Holton then, T.A.and Graham, M.W.A simple and efficient method for directcloning of PCR products using ddT-tailed vectors (a kind of simple and effective method of utilizing the direct clone PCR products of ddT overhang carrier) .NucleicAcids Res.1991,19,1156).Second method is to utilize the terminal enzyme (DNA) activity that does not rely on template of Taq enzyme to add single dTTP to 3 of wire carrier ' end (Marchuk, D., Drumm, M., Saulino, A.and Collins, F.S.Construction ofT-vectors, the a rapid and general system for direct cloning of unmodified PCR product (structure of T carrier, a kind of system of the general original PCR product of direct clone fast) .Nucleic Acids Res.1991,19,1154).The third method is to introduce specific restriction enzyme site in the multiple clone site of plasmid vector, produces 3 ' end with corresponding endonuclease digestion and has the outstanding linear T carrier of single T.In theory, the restriction endonuclease that can be used for preparing the T carrier comprises: XcmI, AhdI/Eam11051/EclHKl/AspEI/NruG0/BspOVI, BfiI/BmrI, HphI/AsuHPI, MboII/NcuI, BfuI/BciVI, HpyAV/Hin4II etc.Wherein XcmI and AhdI and isoschizomers thereof widespread use in preparation T carrier.Other restriction endonuclease or because too expensive, or because too many recognition site is arranged on common cloning vector, thereby the application in preparation T carrier is restricted.
Preceding two kinds of methods exist tailing efficient sequences lower and linear plasmid its two ends in the tailing process problem (Shuman such as to be partially removed sometimes in preparation T carrier process, S.Novel approach tomolecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase (a kind of vaccinia virus topoisomerase that utilizes carries out molecular cloning and polynucleotide synthetic novel method) .J.Biol.Chem.1994,269,32678-32684).Owing to the strict quality control of production firm, its efficient also improves greatly now, can satisfy conventional clone operations, but because its operation steps is more, quality is not easy control, only is applied to several frequently seen carrier at present, and must producing, so price comparison costliness by the company of specialty.The third method also is applied in preparation T carrier at present, has a potential problem but make up the T carrier with restriction endonuclease, and partially digested pre-T carrier is mingled in and can causes the background of non-recombinant conversion too high in the T carrier.In addition, the T carrier that this method produces, look like natural, but be not widely used in practice, do not adopted by a lot of biotech firms yet, except too expensive because of restriction endonuclease, perhaps having on the common cloning vector outside the too many recognition site, a prior reason may be to be used for connecting relatively difficulty behind these enzyme cutting DNAs, dna fragmentation as Ahd I and Xcm I generation has the outstanding of a base at 3 ' end, even than the more difficult connection of flat end (http://www.neb-china.com/cn).Along with the continuous progress of biotechnology, the method for preparing the T carrier is also improved gradually now, and the problem that prepare high quality, stablize, inexpensive T carrier remains vast biological study person's care also is a key of effectively using the T-A clone technology.
Summary of the invention
The method that the purpose of this invention is to provide a kind of new structure T carrier, this method adopt unique biological synthetic technology to produce the T carrier, and be synthetic convenient, the cloning efficiency height, steady quality can improve existing T carrier production cost height, operation steps is more, technical problems such as quality instability.
The solution of the technology of the present invention is: be used for T-A clone's T preparing carriers method, comprise following step:
(1) selecting the plasmid commonly used of high copy number for use, is template with this plasmid, designs four pairs of primers, makes up two kinds at the discrepant mutant plasmid of particular sequence by rite-directed mutagenesis.Make up TTTTAAA and TTTAAAA sequence box respectively at the multiple clone site place of two kinds of mutant plasmids, and in distance TTTTAAA and TTTAAAA sequence box site position far away (>200bp), introduce two different restriction enzyme site BamHI and HindIII respectively;
(2) two kinds of mutant plasmids are imported the bacterium amplification respectively, and the equivalent pNTv1 and the pNTv2 of amplification cut with the restriction endonuclease that can discern the TTTAAA sequence, form two kinds of linear plasmids;
(3) two kinds of plasmid purifying after enzyme is cut, mixing then, sex change, renaturation hybridization produce four kinds of molecules, wherein have two kinds to be parent's molecule, other two kinds be new hybrid molecule.There is unpaired zone in these two kinds of hybrid molecules at original BamHI and HindIII restriction enzyme site place, and promptly BamHI and HindIII restriction enzyme site are destroyed, and wherein a kind of hybrid molecule forms at its 3 ' end has the outstanding linear carrier of single T;
(4) mix plasmid with BamHI and two kinds of restriction enzyme cuttings of HindIII;
(5) mixture after enzyme is cut separates, and removes two kinds of parent's molecules, isolates two kinds of hybrid molecules, and wherein having the outstanding linear carrier hybrid molecule of single T is the T carrier that is used for the T-A clone.
Make up TTTTAAA and TTTAAAA sequence box respectively at the multiple clone site place of two kinds of mutant plasmids, and in distance TTTTAAA and TTTAAAA sequence box site greater than the position of 200bp, introduce two different restriction enzyme sites respectively.
Adopt the restriction endonuclease of identification TTTAAA sequence, as DraI, AhaIII, PauAII, SruI.
Step (3) adopts two kinds of plasmid mixing, sex change, the renaturation hybridization of equimolar amount.
To further narration of the present invention: select a plasmid commonly used, with this plasmid is four pairs of primers of stencil design, make up two kinds at the discrepant mutant plasmid of particular sequence by rite-directed mutagenesis, two kinds of novel plasmids are distinguished called after pNTv1 and pNTv2, introduce a new restriction enzyme site and TTTTAAA sequence box among the pNTv1, introduce another new restriction enzyme site and TTTAAAA sequence box among the pNTv2.TTTTAAA and TTTAAAA sequence box are structured in the multiple clone site place of two kinds of mutant plasmids respectively, and newly in two kinds of mutant plasmids introduce two different restriction enzyme sites, its position in distance TTTTAAA and TTTAAAA sequence box site greater than 200bp.
Two kinds of mutant plasmids are imported the bacterium amplification respectively, and with the equivalent pNTv1 and the pNTv2 restriction endonuclease cutting that can discern the TTTAAA sequence of increasing, mixing, sex change, renaturation, can produce four kinds of molecules after the renaturation hybridization, wherein have two kinds to be parent's molecule, two kinds is new hybrid molecule in addition, with new two kinds of restriction enzyme cuttings introducing, remove parent's molecule, can isolate the T carrier pNTv that is used for the T-A clone.
Characteristics of the present invention are by making up two kinds of mutant plasmids, plasmid is transformed into bacterium increases in a large number, at last by the enzyme cutting from obtaining the purpose carrier.This by biosynthetic natural T carrier, synthetic convenient, production cost is low, cloning efficiency height, steady quality, recombination efficiency height.
Description of drawings
Fig. 1 is a schematic flow sheet of the present invention
Embodiment
Below by embodiment, technical scheme of the present invention is described in further detail.
Embodiment 1: introduce the T preparing carriers method be used for the T-A clone, as Fig. 1:
Select the plasmid commonly used of a high copy number, as pBR322 series plasmid, pUC series plasmid etc.
It is template that this example is selected the pZErO-2 plasmid.
One, be template with the pZErO-2 plasmid, according to its dna sequence dna, design four pairs of primers, make up two kinds at the discrepant mutant plasmid of particular sequence by rite-directed mutagenesis, two kinds of novel plasmids are distinguished called after pNTv1 and pNTv2.The TTTTAAA sequence box of wherein introducing a new restriction enzyme site BamHI among the pNTv1 and can being discerned by the DraI restriction endonuclease, shown in figure step 1: phantom line segments is represented restriction enzyme site BamHI, I and arrow are represented TTTTAAA sequence box among the figure, can be cut by the DraI restriction endonuclease; The TTTAAAA sequence box of introducing a new restriction enzyme site HindIII among the pNTv2 and can being discerned by the DraI restriction endonuclease, shown in figure step 1: two-wire is represented restriction enzyme site HindIII, I and arrow are represented TTTAAAA sequence box among the figure, can be cut by the DraI restriction endonuclease.
Two, two kinds of mutant plasmids are imported the bacterium amplification respectively.The equivalent pNTv1 and the pNTv2 of amplification are cut with the restriction endonuclease DraI that can discern the TTTAAA sequence, form two kinds of linear plasmids, the restriction enzyme site place also can adopt other restriction endonuclease of identification TTTAAA sequence, as AhaIII, PauAII, SruI shown in figure step 2.
Three, plasmid pNTv1 and the pNTv2 purifying after enzyme is cut, mixing then, sex change, renaturation, can produce four kinds of molecules after the renaturation hybridization, wherein there are two kinds to be parent's molecule (pNTv1, pNTv2), in addition two kinds be new hybrid molecule (pNTv3, pNTv4), shown in figure step 3: wherein there is unpaired zone in two kinds of hybrid molecules at original BamHI and HindIII restriction enzyme site place, and promptly BamHI and HindIII restriction enzyme site are destroyed.And pNTv3 has the outstanding linear carrier of single T in its 3 ' end formation.
Four, mix plasmid with BamHI and two kinds of restriction enzyme cuttings of HindIII.Step 4 among the figure.
Five, the mixture after enzyme is cut carries out 0.8% agarose gel electrophoresis, reclaims by rubber tapping and can remove two kinds of parent's molecules, isolates two kinds of hybrid molecules, wherein pNTv3 is the T carrier that is used for the T-A clone, called after pNTv, it accounts for the ratio of half in product, and pNTv4 is a hybrid molecule.Step 5 among the figure.
Also can obtain equifinality with pBR322 series plasmid, pUC series plasmid.
The Performance Detection of embodiment 2:T carrier pNTv
One, pNTv3 of Hui Shouing and pNTv4 mixture mix with 1: 3,1: 5,1: 7 three different mol ratio examples with the DNA that has 3 ' dA, add the T4DNA ligase enzyme, in 16 ℃ of connections.
Two, the electricity of the product after connection transformed competence colibacillus cell TOP 10.
Three, converted product is coated with the LB flat board, 37 ℃ of cultivations.
Four, the PCR of bacterium colony screening and extract plasmid and carry out enzyme and cut evaluation, the result shows that its recombination efficiency reaches more than 90%.